Pathologic Complete Response and Clinical Outcomes in Patients With Localized Soft Tissue Sarcoma Treated With Neoadjuvant Chemoradiotherapy or Radiotherapy: The NRG/RTOG 9514 and 0630 Nonrandomized Clinical Trials.
Sign Up to like & getrecommendations! Published in 2023 at "JAMA oncology"
DOI: 10.1001/jamaoncol.2023.0042
Abstract: Importance Pathologic complete response (pCR) may be associated with prognosis in patients with soft tissue sarcoma (STS). Objective We sought to determine the prognostic significance of pCR on survival outcomes in STS for patients receiving… read more here.
Keywords: rtog 0630; oncology; clinical trials; rtog ... See more keywords
Evaluating machine learning enhanced intelligent-optimization-engine (IOE) performance for ethos head-and-neck (HN) plan generation.
Sign Up to like & getrecommendations! Published in 2023 at "Journal of applied clinical medical physics"
DOI: 10.1002/acm2.13950
Abstract: PURPOSE Varian Ethos utilizes novel intelligent-optimization-engine (IOE) designed to automate the planning. However, this introduced a black box approach to plan optimization and challenge for planners to improve plan quality. This study aims to evaluate… read more here.
Keywords: ioe; ethos; learning; rtog ... See more keywords
Long-term outcomes and toxicities of a large cohort of anal cancer patients treated with dose-painted IMRT per RTOG 0529
Sign Up to like & getrecommendations! Published in 2017 at "Advances in Radiation Oncology"
DOI: 10.1016/j.adro.2017.01.009
Abstract: Purpose To describe the outcomes and toxicities of the largest cohort to date of patients with anal squamous cell carcinoma uniformly treated with concurrent chemoradiation using dose-painted intensity modulated radiation therapy (DP-IMRT) according to RTOG… read more here.
Keywords: per rtog; rtog 0529; rtog; anal cancer ... See more keywords